Leaders | Bob Iger’s encore

Disney brings back a star of the past. But its real problem is the script

Hollywood is suffering from the brutal economics of streaming

Bob Iger, chief executive officer of Walt Disney Co., listens during a Bloomberg Television interview at Disneyland in Shanghai, China, on Friday, June 16, 2017. Iger said he stepped down from Donald Trump's jobs panel two weeks ago following the president's decision to exit the Paris Accord on climate change because businesses must accept responsibility to protect the environment. Photographer: Qilai Shen/Bloomberg via Getty Images

FILM CRITICS often complain that the box office is overrun with sequels. Now so are studios’ head offices. On November 20th Disney announced that Bob Iger, who ran the company for 15 highly successful years until he stepped down in 2020, would go back into the spotlight for a second act as chief executive. Bob Chapek, who lasted less than three years in the role and had presided over a 40% drop in Disney’s share price this year, was sent sloping back to his trailer.

This article appeared in the Leaders section of the print edition under the headline “Disney’s surprise sequel”

Frozen out

From the November 26th 2022 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Leaders

Keir Starmer surrounded by the Eu stars

Sir Keir Starmer should aim higher in his reset with the EU

And he needs to be clearer about what Britain wants

illustration of a world map outlined by a single red electrical cord, with a plug at one end and a socket at the other

To make electricity cheaper and greener, connect the world’s grids

Less than 3% of the world’s power is internationally traded—a huge wasted opportunity


Chinese AI is catching up, posing a dilemma for Donald Trump

The success of cheap Chinese models threatens America’s technological lead


America has an imperial presidency

And in Donald Trump, an imperialist president for the first time in over a century

Tariffs will harm America, not induce a manufacturing rebirth

Donald Trump’s pursuit of tariffs will make the world poorer—and America, too 

How to improve clinical trials

Involving more participants can lead to new medical insights